Medtec上海国际医疗器械设计与制造技术展览会

2025. 09.24-26
上海世博展览馆1号馆&2号馆

2026. 9.1-9.3

上海新国际博览中心 N1-N4

距离展会

FOCUS HEALTHCARE: PIA INTRODUCES NEW MEDITEC® PROCESS MODULE

PIA AUTOMATION IS ONE OF THE WORLD'S LEADING SUPPLIERS IN AUTOMATION.

IN ORDER TO MEET THE INCREASINGLY HIGH DEMANDS OF ITS CUSTOMERS WITHIN THE HEALTHCARE INDUSTRY A NEW, FLEXIBLE PROCESS MODULE HAS BEEN CREATED.

 

PIA‘s meditec® product series combines the advantages of pre-assembled cells – namely high availability and short delivery times – with options for customizing and upgrading according to customer demands, without neglecting GMP requirements.

In addition to PIA's own pick-and-place handling solution, which is suitable for a variety of applications, the highlight of this modular cell concept is the meditec® drive system based on B&R's track technology and control platfrom. With this highly flexible system PIA is able to transport and position the smallest components at high pulse rates as well as parts up to 10 kg per shuttle with high repeating accuracy (+/- 10 μm). The transport system can be operated with different controls to meet customer‘s individual needs even better.

In order to comply with the ever growing demands related to software and controls technology PIA‘s medical division relies on the modern HMI/SCADA solution Zenon by CopaData. Throughout all its modules this software meets all FDA 21 Part 11 requirements and rules (AuditTrail, Batch Report, etc.).

According to the principle „configuring not programming“ the effort for validating the software is being reduced significantly. Furthermore the meditec® process module uses state-of-the-art technology. Equipped with IO Link sensors and OPC UA interfaces it is able to deliver data for various PIA I 4.0 digitisation solutions.

Advatages of the PIA meditec® process module:

  • Modular concept – flexible grid dimension 1200 mm
  • Drive components with small footprint
  • Intelligent transport system
  • Individual control is possible
  • Numerous reports are possible
  • Integration of PIA 4.0 digitisation solutions is possible

The new process module will be introduced at Pharmapack in Paris early February and MedtecLIVE in Nuremberg at the end of March.

 

均普工业自动化(苏州)有限公司(SPIA)成立于2019年7月,是PIA
Group的苏州子公司 ,也是目前自动化装配系统集成这一细分领域的权
威专家。 SPIA拥有强大的产线研发能力,长期活跃在汽车、消费品、电
子,医疗等行业领域,致力于为客户提供量身定制的交钥匙生产系统,开发高端的自动化整体解决方案。

 

PIA Automation (Suzhou) Co., Ltd.(SPIA) is a subsidiary of Ningbo PIA
Automation Holding Co., Ltd. (NPIA) ,founded in 2019 in the city Suzhou and
serves mainly high-end Asian customers with tailor-made innovative
solutions range from automotive industry to electronics and consumer
goods and medical industry. SPIA is also a leading company, which
realizes fully automated assembly systems with integrated tests.

Medtec上海展|从射频到冷冻,再到脉冲电场:房颤消融技术的第三次跃迁

Medtec上海展留意到过去几年,在全球电生理领域的学术会议上,一个技术名词被频繁提及——PFA(Pulse Field Ablation,脉冲电场消融)。

从欧美大型电生理中心,到亚洲越来越多开展房颤消融的医院,这项技术正在迅速进入临床视野。越来越多专家认为,PFA的出现不仅仅是一次技术升级,更可能意味着房颤消融领域的一次重要转折。

查看更多 »

上海医疗器械博览会|“介入无植入”药物球囊DCB全面逆袭:新证据、新指南、新战场

上海医疗器械博览会关注到系统回顾冠状动脉药物涂层球囊(DCB)在冠心病介入治疗中的发展历程、作用机制、核心适用范围与扩展应用。DCB通过“无植入”策略,避免永久金属支架带来的血栓与再狭窄风险,已在支架内再狭窄(ISR)治疗中确立有效性,并在小血管病变、分叉病变、弥漫长病变、急性冠脉综合征(ACS)、糖尿病与高出血风险人群中展现出广阔潜力。多项随机研究与真实世界数据表明,DCB在特定适应症下可与药物支架(DES)疗效相当甚至优于DES。DCB治疗效果高度依赖病变准备质量,强调使用影像指导、非顺应球囊、切割球囊或旋磨等策略。尽管当前仍需更多高质量前瞻性研究来验证其在非ISR病变中的长期安全性与有效性,但DCB正逐步成为冠脉介入治疗中的重要工具。

查看更多 »

Medtec上海展|国内主要瓣膜玩家与行业突破口浅析

Medtec上海展注意到近年,经皮主动脉瓣膜置换(TAVR)/经皮主动脉瓣膜植入(TAVI)相关的器械赛道非常火热。对于临床医生而言,手里的武器库多了是好事,这意味着更多的器械选择。但是,对于TAVR器械厂家(尤其是对于:还处于研发/动物实验/临床试验/拿证前的厂家和/或者产品线相对单一的厂家)而言,可能就意味着压力较大了。本文对国内TAVR市场中国际及国内TAVR主要玩家进行了较详尽的梳理和分析。水平所限,难免谬误/挂一漏万,请各位同道指正。

查看更多 »